Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Randomized Double-Blind Comparison of Sirolimus-Eluting Stent Versus Bare-Metal Stent Implantation in Degenerated Saphenous Vein Grafts

NCT00263263 is registered in ClinicalTrials.gov with Antwerp Cardiovascular Institute Middelheim as lead sponsor.

NCT NCT00263263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00263263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Randomized Double-Blind Comparison of Sirolimus-Eluting Stent Versus Bare-Metal Stent Implantation in Degenerated Saphenous Vein Grafts
Lead sponsor
Antwerp Cardiovascular Institute Middelheim
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2003
Completion date
December 31, 2005
Enrollment
75
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, saphenous vein graft disease, stable angina, unstable angina